DMC Inhaler
for Anaphylaxis

At DMC we think differently about emergency drug delivery.

Our first-generation device aims to treat anaphylaxis by delivering epinephrine through inhalation. 

The technology will utilise the pulmonary pathway to deliver life-saving medication. The large surface area of the lungs allows medications to be rapidly absorbed into the blood stream.

EMERGENCY SOLUTIONS INTENDED FOR THE IMMEDIATE TREATMENT OF LIFE THREATENING CONDITIONS

The inhaler aims to improve upon the current standard of care by being:

* In Phase 1 clinical studies testing inhalation delivery of DMC’s proprietary epinephrine formulation, plasma epinephrine concentrations reached Cmax 8 times faster compared to a widely used autoinjector.

Learn more about our device